High occurrence rate of glaucoma among patients with Alzheimer's disease

European Neurology
A U BayerC Erb

Abstract

The purpose of the current study was to reveal the occurrence rate of glaucoma among patients with Alzheimer's disease (AD). All 112 patients of four nursing homes in Upper Bavaria, Germany, who met the diagnostic criteria of probable AD, were incorporated into the study. Visual field defects and/or optic disc cupping compatible with the diagnosis of glaucoma were found in 29 out of 112 patients with AD (25.9%). When compared to a control group (5.2%) and to the prevalence of glaucoma in western countries revealed in a number of glaucoma surveys (2.6-4.7%), patients with AD may have a significantly increased occurrence rate of glaucoma. In addition, ocular hypertension with normal visual fields and normal optic nerve heads was not found in patients with AD. The prevalence of ocular hypertension in the control group was 7.8% and parallels previous surveys. Therefore, we assume that the optic nerve seems to be less resistant to elevated intraocular pressure levels in AD patients.

Citations

Mar 22, 2007·Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·M Pache
Feb 9, 2012·Current Neurology and Neuroscience Reports·Qiuping Pearl ZhouKathy C Richards
Feb 12, 2013·Molecular Neurobiology·Vishal Jindal
Feb 28, 2013·Translational Psychiatry·S Frost AIBL Research Group
Feb 10, 2009·Journal of Evidence-based Social Work·Laura J PankowDaniel J Luchins
Mar 1, 2006·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Stephan EstermannDavid Goldblum
Apr 27, 2010·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Yukiko YoshidaTsunehiko Ikeda
Jul 20, 2011·QJM : Monthly Journal of the Association of Physicians·A DuthieR L Soiza
Jun 23, 2010·BMC Medical Genetics·Suddhasil MookherjeeKunal Ray
Nov 18, 2009·Cerebrospinal Fluid Research·Peter WostynPeter Paul De Deyn
May 10, 2012·PLoS Genetics·Leonieke M E van KoolwijkCornelia M van Duijn
Oct 3, 2012·PloS One·Sarah F JanssenArthur A B Bergen
Jul 16, 2011·Clinical Ophthalmology·Fani TsolakiMagdalini Tsolaki
Nov 3, 2012·Clinical Ophthalmology·Gabriel Beidoe, Shaker A Mousa
May 31, 2006·Drugs & Aging·Elliott Kanner, James C Tsai
Jan 22, 2011·International Journal of Alzheimer's Disease·Denise A Valenti
Mar 24, 2015·Clinical Neurology and Neurosurgery·Maria P BamboLuis Pablo
Jan 8, 2014·Progress in Retinal and Eye Research·Peter WostynPeter Paul De Deyn
Sep 10, 2013·Journal of Autism and Developmental Disorders·Leonardo Emberti GialloretiPaolo Curatolo
Oct 31, 2013·The British Journal of Ophthalmology·Sivan M ElyashivMichael Belkin
Mar 13, 2014·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·E Timothy O'BrienBeatrice Y J T Yue
Dec 7, 2013·Survey of Ophthalmology·Radouil Tzekov, Michael Mullan
May 12, 2011·Neuromolecular Medicine·Alexandra AbramssonHenrik Zetterberg
Aug 5, 2004·Acta Ophthalmologica Scandinavica·J S RitlandS O Semb
May 11, 2016·Middle East African Journal of Ophthalmology·Anu ChandraFarzana Mahdi
Oct 2, 2015·Journal of Ophthalmic & Vision Research·Sachin Jain, Ahmad A Aref
Sep 18, 2012·Ophthalmic Epidemiology·Yvonne OuFrank A Sloan
May 15, 2013·Seminars in Ophthalmology·Tongabay CumurcuErcan Ozsoy
Jun 30, 2015·Fluids and Barriers of the CNS·Peter WostynVeva De Groot
May 16, 2014·Molecular Neurobiology·Vishal Jindal
Nov 28, 2014·Frontiers in Aging Neuroscience·David P CrabbHaogang Zhu
Feb 19, 2014·The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques·Andrée-Anne PelletierHélène Kergoat
Jan 17, 2012·Journal français d'ophtalmologie·S LeruezD Milea
Dec 30, 2008·Journal of the American Medical Directors Association·Guillaume CarcenacHélène Kergoat

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.

Related Papers

Acta Ophthalmologica
Daniella Bach-HolmLars Vedel Kessing
Frontiers in Bioscience : a Journal and Virtual Library
Stuart J McKinnon
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology
V ParisiF Pierelli
© 2022 Meta ULC. All rights reserved